CUSIP: 45409B412
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / IQ S&P HGH YLD
-
Total 13F shares
-
377,119
-
Share change
-
-40,063
-
Total reported value
-
$8,009,813
-
Price per share
-
$21.24
-
Number of holders
-
16
-
Value change
-
-$815,477
-
Number of buys
-
6
-
Number of sells
-
13
Quarterly Holders Quick Answers
What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 45409B412:
Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q4 2022
As of 31 Dec 2022,
INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
377,119 shares.
The largest 10 holders included
JANE STREET GROUP, LLC, FLOW TRADERS U.S. LLC, CITADEL ADVISORS LLC, LPL Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RAYMOND JAMES & ASSOCIATES, ADVISOR GROUP HOLDINGS, INC., BANK OF AMERICA CORP /DE/, Capstone Triton Financial Group, LLC, and Castleview Partners, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.